Pfizer to Sell Capsugel
Capsugel will be sold for $2.375 billion in cash.
Pfizer announced plans to sell Capsugel (Peapack, NJ), the world’s leading provider of pharmaceutical and dietary supplement capsules, to private equity firm Kohlberg Kravis Roberts & Co. Capsugel will be sold for $2.375 billion in cash.
Last year, Capsugel generated approximately $750 million in revenue and manufactured more than 180 billion hard capsules. The transaction is expected to be completed this year. Capsugel will maintain its corporate presence in the United States and its global headquarters in New Jersey.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
September 19th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
